- NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
- 704.376.3688
- sbuchanan@meckmed.org
- All
- Alcoholic Hepatitis
- Ascites
- Barrett’s Esophagus
- Celiac Disease
- Colorectal Cancer Screening
- Constipation
- Crohn’s Disease
- Eosinophilic Esophagitis
- Eosinophilic Gastritis and/or Eosinophilic Duodenitis
- Gastroesophageal Reflux Disease
- Intraductal Papillary Mucinous Neoplasms
- NEWS
- Nonalcoholic Steatohepatitis
- Primary Biliary Cholangitis
- Primary Sclerosing Cholangitis
- Short Bowel Syndrome
- Ulcerative Colitis
- Uncategorized
January 31, 2022
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects With Eosinophilic Esophagitis Study title A Phase […]
January 31, 2022
VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome Study title VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome Disease or condition Short bowel […]
January 31, 2022
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) Study title Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) Disease or condition Primary Biliary Cholangitis Study type Interventional […]
January 31, 2022
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis Study title […]
January 31, 2022
A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) (Harmony) Study title A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically […]
January 31, 2022
A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and Fibrosis Study […]
September 10, 2021
A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and Fibrosis Study […]
May 31, 2021
Study title Phase 1, Open Label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in […]
May 31, 2021
Study title A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis (QUASAR) Disease or condition Ulcerative colitis Study type Interventional (Clinical Trial) […]